Efficacy, safety and implementation outcomes of Cabotegravir plus Rilpivirine long-acting by country in the Cabotegravir and rilpivirine implementation study in European locations (CARISEL)

被引：0
|
作者：
Jonsson-Oldenbuettel, C. [1 ,2 ]
Ghosn, J. [3 ,4 ]
Sierra, J. Olalla [5 ]
van der Valk, M. [6 ]
Lutz, T. [7 ]
Belkhir, L. [8 ]
van Welzen, B. J. [9 ]
Hove, K. [10 ]
Ait-Khaled, M. [10 ]
DeMoor, R. [11 ]
Bontempo, G. [12 ]
Latham, C. L. [12 ]
Ngenzi, B. [13 ]
Okoli, C. [10 ]
Gutner, C. A. [12 ]
Iyer, S. [14 ]
Gill, M. [15 ]
Czarnogorski, M. [12 ]
D'Amico, R. [12 ]
van Wyk, J. [10 ]
机构：
[1] MVZ Munchen Goethepl, Munich, Germany
[2] MUC Res GmbH, Munich, Germany
[3] Univ Paris, INSERM, UMR 1137, IAME, Paris, France
[4] Hop Bichat Claude Bernard, Serv Malad Infect & Tropicales, AP HP, Paris, France
[5] Costa Sol Hosp, Dept Internal Med, Marbella, Spain
[6] Univ Amsterdam, Amsterdam Inst Infect & Immun, Dept Infect Dis, Amsterdam, Netherlands
[7] Infektio Res, Frankfurt, Germany
[8] Clin Univ St Luc, Brussels, Belgium
[9] Univ Med Ctr Utrecht, Utrecht, Netherlands
[10] ViiV Healthcare, Brentford, England
[11] GSK, Collegeville, PA USA
[12] ViiV Healthcare, Durham, NC USA
[13] ViiV Healthcare, Wavre, Belgium
[14] GSK, Bangalore, Karnataka, India
[15] GSK, Brentford, England
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
EACS2023:
引用
收藏
页码：193 / 195
页数：3
相关论文
共 50 条
  • [1] The use and utility of toolkits in supporting cabotegravir plus rilpivirine long-acting implementation in the CARISEL (Cabotegravir And Rilpivirine Implementation Study in European Locations) study
    Trehan, Rekha
    Gutner, Cassidy
    Okoli, Chinyere
    Ghosn, Jade
    Vera, Francisco
    Florence, Eric
    Lutz, Thomas
    van der Valk, Marc
    Czarnogorski, Maggie
    [J]. HIV MEDICINE, 2023, 24 : 93 - 93
  • [2] Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) Study
    Gutner, Cassidy A.
    van der Valk, Marc
    Portilla, Joaquin
    Jeanmaire, Eliette
    Belkhir, Leila
    Lutz, Thomas
    Demoor, Rebecca
    Trehan, Rekha
    Scherzer, Jenny
    Pascual-Bernaldez, Miguel
    Ait-Khaled, Mounir
    Hernandez, Beatriz
    de Ruiter, Annemiek
    Anand, Savita Bakhshi
    Low, Emma L.
    Hadi, Monica
    Barnes, Nicola
    Sevdalis, Nick
    Mohammed, Perry
    Czarnogorski, Maggie
    [J]. JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2024, 23
  • [3] Implementation of long-acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations
    Gutner, Cassidy A.
    Hocqueloux, Laurent
    Jonsson-Oldenbuettel, Celia
    Vandekerckhove, Linos
    van Welzen, Berend J.
    Slama, Laurence
    Crusells-Canales, Maria
    Sierra, Julian Olalla
    DeMoor, Rebecca
    Scherzer, Jenny
    Ait-Khaled, Mounir
    Bontempo, Gilda
    Gill, Martin
    Patel, Natasha
    D'Amico, Ronald
    Hove, Kai
    Baugh, Bryan
    Barnes, Nicola
    Hadi, Monica
    Low, Emma L.
    Anand, Savita Bakhshi
    Hamilton, Alison
    Garges, Harmony P.
    Czarnogorski, Maggie
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 (07)
  • [4] Implementation of cabotegravir and rilpivirine long-acting (CAB plus RPV LA): primary results from the CAB plus RPV Implementation Study in European Locations (CARISEL)
    Van Welzen, B.
    Vandekerckhove, L.
    Jonsson-Oldenbuettel, C.
    Hocqueloux, L.
    Ait-Khaled, M.
    Bontempo, G.
    DeMoor, R.
    Scherzer, J.
    D'Amico, R.
    Barnes, N.
    Hadi, M.
    Low, E.
    Anand, S.
    Czarnogorski, M.
    Gutner, C.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 71 - 72
  • [5] Perceptions of cabotegravir and rilpivirine long-acting (CAB plus RPV LA) from patients in the CAB plus RPV implementation study in European locations (CARISEL)
    Lutz, Thomas
    Jeanmaire, Eliette
    Portilla, Joaquin
    Scherzer, Jenny
    Trehan, Rekha
    Pascaul-Bernaldez, Miguel
    DeMoor, Rebecca
    Ait-Khaled, Mounir
    Hadi, Monica
    Anand, Savita Bakhshi
    Low, Emma L.
    Czarnogorski, Maggie
    Gutner, Cassidy A.
    Neumann, Jeanette
    [J]. HIV MEDICINE, 2023, 24 : 20 - 21
  • [6] Perceptions of cabotegravir and rilpivirine long-acting (CAB plus RPV LA) from patients in the CAB plus RPV Implementation Study in European Locations (CARISEL)
    Lutz, T.
    Jeanmaire, E.
    Portilla, J.
    Scherzer, J.
    Trehan, R.
    Pascual-Bernaldez, M.
    DeMoor, R.
    Ait-Khaled, M.
    Hadi, M.
    Anand, S.
    Low, E.
    Czarnogorski, M.
    Gutner, C.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 117 - 118
  • [7] Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir plus Rilpivirine Long-Acting Into European Clinical Settings
    Jonsson-Oldenbuettel, Celia
    Ghosn, Jade
    van der Valk, Marc
    Florence, Eric
    Vera, Francisco
    De Wit, Stephane
    Rami, Agathe
    Bonnet, Fabrice
    Hocqueloux, Laurent
    Hove, Kai
    Ait-Khaled, Mounir
    DeMoor, Rebecca
    Bontempo, Gilda
    Latham, Christine L.
    Gutner, Cassidy A.
    Iyer, Supriya
    Gill, Martin
    Czarnogorski, Maggie
    D'Amico, Ronald
    van Wyk, Jean
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 96 (05) : 472 - 480
  • [8] Perspectives on the acceptability, appropriateness, feasibility, barriers, and facilitators from patients receiving cabotegravir plus rilpivirine long-acting injectable treatment (CAB plus RPV LA): interim results from the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL)
    Hocqueloux, L.
    Gutner, C.
    DeMoor, R.
    Gill, M.
    Trehan, R.
    D'Amico, R.
    Tomkins, S.
    Schroeder, M.
    Bontempo, G.
    Ait-Khaled, M.
    Hadi, M.
    Anand, S. Bakhshi
    Low, E. L.
    Jeanmaire, E.
    Crusells Canales, M.
    Vandekerckhove, L.
    Bonnet, F.
    Olalla Sierra, J.
    Czarnogorski, M.
    [J]. HIV MEDICINE, 2021, 22 : 99 - 99
  • [9] Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL): examining health care staff attitudes during a hybrid III implementation-effectiveness trial implementing cabotegravir plus rilpivirine long-acting injectable (CAB plus RPV LA) for people living with HIV (PLHIV)
    Gutner, C.
    Dakhia, S.
    Gill, M.
    Pascual-Bernaldez, M.
    Hernandez, B.
    Rami, A.
    Portilla, J.
    Lutz, T.
    van der Valk, M.
    Florence, E.
    Barnes, N.
    Cooper, O.
    Filipenko, D.
    Hamilton, A.
    Bosse, M.
    Czarnogorski, M.
    [J]. HIV MEDICINE, 2021, 22 : 114 - 115
  • [10] Safety and effectiveness outcomes from the Carisel study: phase 3b hybrid-3 implementation study integrating cabotegravir plus rilpivirine long-acting into European clinical settings
    Jonsson-Oldenbuettel, C.
    Ghosn, J.
    van der Valk, M.
    Florence, E.
    Vera, F.
    Ait-Khaled, M.
    Bontempo, G.
    Latham, C.
    Gutner, C. A.
    Iyer, S.
    DeMoor, R.
    Gill, M.
    Czarnogorski, M.
    van Wyk, J.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 241 - 242
12345